-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
-
US races to secure rare earths to rebuild depleted arsenal
-
Matthew Perry drug middleman jailed for two years
-
Warsh confirmed as Fed chair as central bank faces Trump assault
US vaccine panel upends hepatitis B advice in latest Trump-era shift
An advisory panel appointed by the Trump administration's vaccine-skeptic health secretary voted Friday to stop recommending that all newborns in the United States receive a hepatitis B vaccine.
The move to end the decades-old recommendation is the panel's latest contentious about-face on vaccine policy since its overhaul by Health Secretary Robert F. Kennedy Jr. earlier this year.
US health authorities previously recommended all babies, not just those born to mothers believed to have hepatitis B, receive the first of three vaccine doses just after birth.
The approach aimed, in part, to prevent transfers from mothers who unknowingly had hepatitis B or had falsely tested negative, and had virtually eradicated infections of the potentially deadly liver disease among young people in the country.
After delaying the vote by a day, the panel on Friday passed its new recommendation for "individual-based decision-making," in consultation with a health care provider, when children are born to mothers testing negatively for the disease.
The decision to vaccinate at birth should "consider vaccine benefits, vaccine risks, and infection risks."
The new recommendation was immediately condemned by several medical groups who noted widespread shortcomings in US maternal health screening as well as the possibility of infections from others.
"This irresponsible and purposely misleading guidance will lead to more hepatitis B infections in infants and children," American Academy of Pediatrics President Susan J. Kressly said in a statement.
The vote was 8-3. Trump-appointed officials at the Centers for Disease Control and Prevention (CDC) are expected to formally adopt the recommendations at a later date.
The panel also voted to recommend that babies who are not vaccinated at birth wait at least two months to get the initial dose, and that blood tests be done to measure antibodies before a second dose.
- Panel overhaul -
After becoming health secretary, Kennedy sacked every member of the once-staid Advisory Committee on Immunization Practices (ACIP), replacing them with figures whose vaccine-skeptic views track more closely with his own.
It has since set to work on reviewing prior recommendations -- already tweaking advice on Covid-19 and measles shots.
Medical experts fear the push could further contribute to declining vaccination rates in the United States.
The panel on Friday also began a broader review of the childhood vaccination schedule, and sparked further controversy by allowing testimony from lawyer Aaron Siri, a close Kennedy associate known for spreading unfounded theories on the subject.
While US President Donald Trump vocally supports Kennedy's policies, some in the Republican Party have pushed back, notably Louisiana Senator Bill Cassidy.
Medical doctor Cassidy condemned the ACIP decision on Friday, noting the original recommendation was never "a mandate" to get the jab.
CDC officials "should not sign these new recommendations and instead retain the current, evidence-based approach," he said on X.
Cassidy's expression of alarm, like his prior statements against Kennedy, provoked criticism after he provided the key vote to confirm the health secretary in February.
- 'Do no harm' -
The United States had urged universal vaccination at birth against hepatitis B since 1991, advice also recommended by China, Australia and the World Health Organization.
But several ACIP members argued Friday's decision would align the United States with other economically developed countries such as France and Britain.
The repercussions of the ACIP's vaccine recommendations are broad because federal guidelines often dictate whether vaccines are paid for by health insurance companies in the United States, where a vaccine can cost hundreds of dollars.
But the committee's influence is waning amid withering criticism from the US scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.
Ahead of the vote, Dr. Cody Meissner, one of the few dissenting voices on the advisory committee, urged his colleagues not to change the current recommendations.
"Do no harm is a moral imperative. We are doing harm by changing this wording," he warned.
P.Smith--AT